Hudson Capital Management LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1727342 RAMSEY, NJ

Position in BMY

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$6,300,977

-$317,211 QoQ

Shares Held

109,354

+0.2% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

3.07%

of 13F equity value

Holder Rank

#488

of 2,506 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Hudson Capital Management LLC holds $13,852,767 across 5 Drug Manufacturers - General names. BMY ranks #2 (45.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	52,947	$6,689,323
2	BMY	Bristol Myers Squibb Co This page	109,354	$6,300,977
3	NVS	Novartis AG	2,040	$319,708
4	MRK	Merck & Co., Inc.	2,196	$282,186
5	JNJ	Johnson & Johnson	1,026	$260,573

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,300,977	109,354	+0.2%	Shares	Sole	2026-07-14
2026-03-31	$6,618,188	109,121	+6.0%	Shares	Sole	2026-04-13
2025-12-31	$5,553,230	102,952	+6.5%	Shares	Sole	2026-01-21
2025-09-30	$4,357,742	96,624	+8.7%	Shares	Sole	2025-10-21
2025-06-30	$4,113,514	88,864	+3.0%	Shares	Sole	2025-07-28
2025-03-31	$5,264,229	86,313	+5.1%	Shares	Sole	2025-04-11
2024-12-31	$4,645,329	82,131	-7.4%	Shares	Sole	2025-01-17
2024-09-30	$4,586,699	88,649	+1.2%	Shares	Sole	2024-10-09
2024-06-30	$3,638,318	87,607	+27.9%	Shares	Sole	2024-07-16
2024-03-31	$3,714,429	68,494	+10.7%	Shares	Sole	2024-04-19
2023-12-31	$3,173,677	61,853	+13.9%	Shares	Sole	2024-01-11
2023-09-30	$3,151,281	54,295	+19.3%	Shares	Sole	2023-10-27
2023-06-30	$2,909,533	45,497	+9.6%	Shares	Sole	2023-07-13
2023-03-31	$2,876,711	41,505	+10.9%	Shares	Sole	2023-04-18
2022-12-31	$2,691,577	37,409	+6.4%	Shares	Sole	2023-01-18
2022-09-30	$2,498,671	35,148	—	Shares	Sole	2022-10-12
No filing history on record for this holder in this stock.